NCT01904695View on ClinicalTrials.gov

Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Primary HypertensionHypertension, Resistant to Conventional Therapy
Interventions
DRUG

Herbs

Herbs 180ml by mouth every 12 hours for 8 weeks

DRUG

Antihypertensive drugs

Thiazide diuretics and ACE inhibitor and β-blocker in different dosage determined by the physician for 8 weeks

Trial Locations (1)

100700

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing

All Listed Sponsors
collaborator

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER

lead

China Academy of Chinese Medical Sciences

OTHER

NCT01904695 - Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study | Biotech Hunter | Biotech Hunter